Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial

• Päätekijät: Max Nieuwdorp (Tekijä), Judith Zeevenhooven (Tekijä), Clara Marieke Andrea de Bruijn (Tekijä), Arine Vlieger (Tekijä), Marc Alexander Benninga (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMJ Publishing Group, 2020-02-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background Irritable bowel syndrome (IBS) is a common chronic medical condition, in both children and adults. Despite the availability of effective (non)pharmacological treatments, symptoms persist in a significant amount of patients with IBS. Faecal microbiota transplantation (FMT) may be an effect...